1 |
Yuan S, Larsson SC. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism 2023;:155533. [PMID: 36907247 DOI: 10.1016/j.metabol.2023.155533] [Reference Citation Analysis]
|
2 |
Xu Z, Yu Z, Li S, Tian Z, Yuan J, You F. Exploration of the core gene signatures and mechanisms between NAFLD and sarcopenia through transcriptomic level. Front Endocrinol 2023;14. [DOI: 10.3389/fendo.2023.1140804] [Reference Citation Analysis]
|
3 |
Dowling P, Gargan S, Swandulla D, Ohlendieck K. Fiber-Type Shifting in Sarcopenia of Old Age: Proteomic Profiling of the Contractile Apparatus of Skeletal Muscles. Int J Mol Sci 2023;24. [PMID: 36768735 DOI: 10.3390/ijms24032415] [Reference Citation Analysis]
|
4 |
Ohlendieck K. Two-CyDye-Based 2D-DIGE Analysis of Aged Human Muscle Biopsy Specimens. Methods in Molecular Biology 2023. [DOI: 10.1007/978-1-0716-2831-7_19] [Reference Citation Analysis]
|
5 |
Xin C, Guan X, Wang L, Liu J. Integrative Multi-Omics Research in Cerebral Palsy: Current Progress and Future Prospects. Neurochem Res 2022. [DOI: 10.1007/s11064-022-03839-y] [Reference Citation Analysis]
|
6 |
Zhang T, Cheng JK, Hu YM. Gut microbiota as a promising therapeutic target for age-related sarcopenia. Ageing Res Rev 2022;81:101739. [PMID: 36182084 DOI: 10.1016/j.arr.2022.101739] [Reference Citation Analysis]
|
7 |
De Paepe B. The Cytokine Growth Differentiation Factor-15 and Skeletal Muscle Health: Portrait of an Emerging Widely Applicable Disease Biomarker. IJMS 2022;23:13180. [DOI: 10.3390/ijms232113180] [Reference Citation Analysis]
|
8 |
Lynch DH, Spangler HB, Franz JR, Krupenevich RL, Kim H, Nissman D, Zhang J, Li Y, Sumner S, Batsis JA. Multimodal Diagnostic Approaches to Advance Precision Medicine in Sarcopenia and Frailty. Nutrients 2022;14:1384. [DOI: 10.3390/nu14071384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|